Anika Therapeutics, Inc.: revenue
| Value | {"amount": 75081000, "concept": "us-gaap:SalesRevenueNet", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/78c5781b-4818-4041-8ec4-1ffd2209a290
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-16-008487Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/revenue/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/78c5781b-4818-4041-8ec4-1ffd2209a290
History
- supersedes {"amount": 75081154, "concept": "us-gaap:SalesRevenueNet", "currency": "USD"} (evidence 0001171843-14-001240)